Skip to main content
Log in

Anti-Cardiolipin Antibodies in Patients with Inflammatory Bowel Disease

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Elevated levels of anti-cardiolipin antibodiesare associated with an increased risk for venous andarterial thrombosis. In patients with inflammatory boweldisease thrombosis is a well known complication. We determined the prevalence of elevatedanti-cardiolipin antibodies in 136 patients withinflammatory bowel disease compared with 136 healthycontrols and analyzed thromboembolic complications inpatients with increased anti-cardiolipin antibodylevels. Anti-cardiolipin antibody titers weresignificantly elevated in patients with Crohn's disease(5.7 units/ml) and ulcerative colitis (5.3 units/ml)compared to the control group (2.5 units/ml). We foundno correlation between disease activity andanti-cardiolipin antibody levels. Seven patients haddeep venous thrombosis in their history, in three ofthem this was complicated by pulmonary embolism. In onlytwo of the seven patients with deep venous thrombosiswere anti-cardiolipin antibody levels increased. Inconclusion, anti-cardiolipin antibody titers were significantly increased in patients withinflammatory bowel disease. Elevated anti-cardiolipinantibody levels appear to play no role in thepathogenesis of thromboembolic events in patients withinflammatory bowel disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Wakefield AJ, Sawyerr AM, Hudson M, Dhillon AP, Pounder RE: Smoking, the oral contraceptive pill, and Crohn's disease. Dig Dis Sci 36:1147-1150, 1991

    Google Scholar 

  2. Wakefield AJ, Dhillon AP, Rowles PM, Sawyerr AM, Pittilo RM, Rowles PM, Lewis AAM: Pathogenesis of Crohn's disease: Multifocal gastrointestinal infarction. Lancet 2:1057-1062, 1989

    Google Scholar 

  3. Eber B, Schumacher M, Auer-Grumbach P, Toplak H, Klein W: Increased anticardiolipin antibodies in patients with restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 69:1255-1258, 1992

    Google Scholar 

  4. Love PE, Santoro SA: Anticardiolipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 112:682-698, 1990

    Google Scholar 

  5. Mackworth-Young C: Antiphospholipid antibodies: More than just a disease marker? Immunol Today 11:60-65, 1990

    Google Scholar 

  6. Wiethölter H: Anticardiolipid-Syndrom. Dtsch Med Wochenschr 117:194-196, 1992

    Google Scholar 

  7. Harris EN, Gharavi AE, Patel SP, Hughes GRV: Evaluation of the anticardiolipin antibody test. Clin Exp Immunol 68:215-222, 1987

    Google Scholar 

  8. Harris EN: Annotation: Anticardiolipid antibodies. Br J Haematol 74:1-9, 1990

    Google Scholar 

  9. Harris EN: Reassessment of the anticardiolipid syndrome. J Rheumatol 17:733-735, 1990

    Google Scholar 

  10. Ginsburg KS, Liang MH, Newcomer L, Goldhaber SZ, Schur PH, Hennekens CH, Stampfer MJ: Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 117:997-1002, 1992

    Google Scholar 

  11. Koenigs KP, McPhedran P, Spiro HM: Thrombosis in inflammatory bowel disease. J Clin Gastroenterol 9:627-631, 1987

    Google Scholar 

  12. Talbot RW, Heppel J, Dozois RR, Beart RW: Vascular complications of inflammatory bowel disease. Mayo Clin Proc 61:140-145, 1986

    Google Scholar 

  13. Vianna JL, D'Cruz DP, Khamashta MA, Asherson RA, Hughes GRV: Anticardiolipin antibodies in a patient with Crohn's disease and thrombosis. Clin Exp Rheumatol 10:165-168, 1992

    Google Scholar 

  14. Papi C, Ciaco A, Acierno G, Di Battista G, Figa Talamanca L, Lo Russo F, Natali G, Capurso L: Antiphospholipid antibodies in a patient with severe ulcerative colitis and cerebraldural sinus thrombosis. Ital J Gastroenterol 25(suppl 1):136, 1993

    Google Scholar 

  15. Mevorach D, Goldberg Y, Gomori JM, Rachmilewitz D: Antiphospholipid syndrome manifested by ischemic stroke in a patient with Crohn's disease. J Clin Gastroenterol 22:141-143, 1996

    Google Scholar 

  16. Milandre I, Monges D, Dor V, Juhan-Vague I, Khalil R: Cerebral phlebitis and Crohn disease. Rev Neurol Paris 148:139-144, 1992

    Google Scholar 

  17. Papi C, Ciaco A, Acierno G, Di-Battista G, Talamanca LF, Lo-Russo F, Natali G, Capruso L: Severe ulcerative colitis, dural sinus thrombosis, and the lupus anticoagulant. Am J Gastroenterol 90:1514-1517, 1995

    Google Scholar 

  18. Silburn PA, Sandstrom PA, Staples C, Mowat P, Boyle RS: Deep cerebral venous thrombosis presenting as an encephalic illness. Postgrad Med J 72:355-368, 1996

    Google Scholar 

  19. Greenfield SM, Teare JP, Whitehead MW, Thompson RP: Amaurosis fugax, Crohn's disease and the anticardiolipin antibody. Lupus 2:271-273, 1993

    Google Scholar 

  20. Lennard-Jones JE: Classification of inflammatory bowel disease. Scand J Gastroenterol 24( suppl 170:2-6, 1989

    Google Scholar 

  21. Best WR, Becktel JM, Singleton JW: Rederived value s of the eight coefficients of the Crohn's disease activity index (CDAI). Gastroenterology 77:843-846, 1979

    Google Scholar 

  22. Truelove SC, Witts LJ: Cortisone in ulcerative colitis. BMJ 1:1041-1048, 1955

    Google Scholar 

  23. Fox E, Kuo J, Tilling L, Ulrich C: Sigma Stat User's Manual. San Rafael, California, Jandel Scientific, 1994

    Google Scholar 

  24. Bargen JA, Barker NW: Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch Intern Med 58:17-31, 1986

    Google Scholar 

  25. Lake AM, Stauffer JQ, Stuatz MJ: Hemostatic alterations in inflammatory bowel disease: Response to therapy. Am J Dig Dis 23:897-902, 1978

    Google Scholar 

  26. Lee JCL, Spittel JA, Sauer WG, Owen ACA, Thompson JH: Hype rcoagulability associated with chronic ulcerative colitis: Changes in blood coagulation factors. Gastroenterology 54:76-85, 1968

    Google Scholar 

  27. Lam A, Borda IT, Inwood MJ, Thomson S: Coagulation studies in ulcerative colitis and Crohn's disease. Gastroenterology 68:245-251, 1975

    Google Scholar 

  28. Braverman D, Bogoch A: Arterial thrombosis in ulcerative colitis. Am J Dig Dis 23:1148-1150, 1978

    Google Scholar 

  29. Aadland E, Ødegaard OR, Rø seth A, Try K: Free protein S deficiency in patients with chronic inflammatory bowel disease. Scand J Gastroenterol 27:957-960, 1992

    Google Scholar 

  30. Talstad I, Rootwelt K, Gjone E: Thrombocytosis in ulcerative colitis and Crohn's disease. Scand J Gastroenterol 8:135-138, 1973

    Google Scholar 

  31. Morowitz DA, Allen LW, Kirsner JB: Thrombocytosis in chronic inflammatory bowel disease. Ann Int Med 68:1013-1021, 1968

    Google Scholar 

  32. Vecchi M, Cattaneo M, de-Franchis R, Mannucci PM: Risk of thromboembolic complications in patients with inflammatory bowel disease. Study of hemostasis measurements. Int J Clin Lab Res 21:165-170, 1991

    Google Scholar 

  33. Chamouard P, Grunebaum L, Wiesel ML, Freyssinet JM, Duclos B, Cazenave JP, Baumann R: Prevalence and significance of anticardiolipin antibodies in Crohn' s disease. Dig Dis Sci 39:1501-1504, 1994

    Google Scholar 

  34. Chiarantini E, Valanzano R, Liotta AA, Cellai AP, Fedi S, Ilari I, Prisco D, Tonelli F, Abbate R: Hemostatic abnormalities in inflammatory bowel disease. Thromb Res 82:137-146, 1996

    Google Scholar 

  35. Stevens TRJ, Harley SL, Groom JS, Cambridge G, Leaker B, Blake DR, Rampton DS: Anti-endothelial cell antibodies in inflammatory bowel disease. Dig Dis Sci 38:426-432, 1993

    Google Scholar 

  36. Patel RT, Pall AA, Stokes R, Birch D, Hail C, Adu D, Keigley MRB: Autoantibody prevalence and association in inflammatory bowel disease. Eur J Gastroenterol Hepatol 6:705-709, 1994

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aichbichler, B.W., Petritsch, W., Reicht, G.A. et al. Anti-Cardiolipin Antibodies in Patients with Inflammatory Bowel Disease. Dig Dis Sci 44, 852–856 (1999). https://doi.org/10.1023/A:1026646816672

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026646816672

Navigation